Results 181 to 190 of about 469,783 (298)

La atención primaria en el control de un brote de hepatitis en un círculo infantil Primary health care in the control of an outbreak of hepatitis in a day care center

Revista Cubana de Investigaciones Biomédicas, 2006
Se realizó un control de foco de hepatitis aguda en un círculo infantil, estudiando 118 niños y 37 trabajadores, mediante encuestas epidemiológicas, exámenes físicos y toma de muestras para: transaminasa glutámico pirúvico; dosificaciones de ...
Ricardo Almeida Varela, Antonio M. González Griego, Victoria Ramírez Albajes   +2 more
doaj  

Standardized Management Pathway to Prevent Acute Rejection After Liver Transplantation Following ICI Therapy for Downstaging HCC

Health Care Science, EarlyView.
Findings indicate that within a standardized clinical pathway integrating structured immunosuppression, therapeutic drug monitoring, and early complication surveillance, liver transplantation after ICI exposure can be performed safely without increased rejection risk.
Ning Wang, Zebin Zhu, Hao Zheng, Can Qi, Xiaodong Yuan, Xuefeng Li, Zhijun Xu, Jiwei Qin, Wei Wu, Jizhou Wang, Ruipeng Song, Zhiyong Guo, Lianxin Liu, Shu‐Geng Zhang, Björn Nashan   +14 more
wiley   +1 more source

Unintended Consequences of Life‐Saving Pharmaceutical Innovations: How HAART Led to the Resurgence of Syphilis

Health Economics, EarlyView.
ABSTRACT Syphilis, a sexually transmitted infection that can lead to serious health complications, was almost eliminated in the United States by 2000. But since then, its incidence began to increase, recently reaching a 60‐year peak. We suggest that the introduction of the highly active antiretroviral therapy (HAART) drug regimen, which transformed HIV
David Beheshti, Scott Cunningham, Nir Eilam   +2 more
wiley   +1 more source

Environmental considerations in hepatitis E virus transmission: Is there a missing link? [PDF]

World J Hepatol
Campbell R, Russell C, Izopet J, Nassim K, Sonderup M, Pischke S, Wallace SJ, Madden RG.   +7 more
europepmc   +1 more source

Molnupiravir is effective against hepatitis E virus infection in an animal model. [PDF]

Hepatol Commun
Wu S, Chew NF, Ma X, Situ J, Shun EH, Li C, Ip JD, Ho SS, Zhang AJ, Tsoi JY, Chan WM, Ma W, Liang Y, Mao W, Chen KWY, Yin F, To KK, Yuan S, Chan JF, Zhu L, Huang Y, Sridhar S.   +21 more
europepmc   +1 more source

Hepatitis E virus in wild boar from Poland. [PDF]

Sci Rep
Didkowska A, Klich D, Matusik K, Di Lecce E, D'Alessio N, Serra F, Levante M, Ptak M, Kwiecień E, Di Bartolo I, De Sabato L, Fusco G, Filip-Hutsch K, Anusz K, Amoroso MG.   +14 more
europepmc   +1 more source

Absence of hepatitis E virus in hedgehogs in northern Italy in 2022-2024. [PDF]

Virol J
Arnaboldi S, Benevenia R, Righi F, Scarazzato A, Lavazza A, Lelli D, Trogu T, Losio MN, Bertasi B.   +8 more
europepmc   +1 more source

Phosphoinositide kinase PIKfyve inhibitor apilimod blocks hepatitis E virus infection. [PDF]

eGastroenterology
Ring JJ, Schlienkamp S, Goussain Darido ML, Zhang X, Pinto Veiga O, Haase JA, Richter E, Gömer A, Fu RM, Dao Thi VL, Ulrich RG, Klöhn M, Todt D, Bader V, Winklhofer KF, Kinast V, Neyts J, Kaptein SJF, Steinmann E, Brüggemann Y.   +19 more
europepmc   +1 more source

Recurrent Hepatitis E in Pregnancy

Pakistan Journal of Medicine and Dentistry
Hepatitis E virus (HEV) is a single stranded RNA virus that causes large scale epidemics of acute viral hepatitis, particularly in developing couniries.
Rehana Yasmeen’, Rubina Hussain, Anjum Afshan   +2 more
doaj  

Hepatitis E virus replication is maintained in proliferative cells within the intestinal crypt. [PDF]

Sci Adv
Prallet S, Maier N, Li A, Afting C, Huang HE, Hu J, Toprak E, Keya DP, Colasanti O, León-Janampa N, Marlet J, Beisel C, Mogler C, Puchas P, Behrendt P, Boettler T, Steinmann E, Saha S, Laketa V, Lohmann V, Wittbrodt J, Hermann C, Dill MT, Dao Thi VL.   +23 more
europepmc   +1 more source